Parasite ELISA Test Kit Range
Parasites are organisms that rely on a host for survival, often causing a range of infectious diseases that can impact human and animal health. These infections are caused by protozoa, helminths (worms), or ectoparasites such as ticks and lice, with some capable of leading to severe or chronic illnesses if left undiagnosed. Rapid and accurate detection is essential for effective disease management, and enzyme-linked immunosorbent assay (ELISA) technology provides a reliable solution for identifying parasite-specific antigens or antibodies in clinical samples.
Aspect Scientific supplies high-quality ELISA test kits, enabling precise and efficient parasite diagnostics to support healthcare professionals and research laboratories.
Ascaris Lumbricoides
Ascariasis is an infection caused by a parasitic roundworm, Ascaris Lumbricoides. This is the most common intestinal worm infection. It is found in association with poor personal hygiene, poor sanitation, and in places where human faeces are used as fertiliser. Intake of food or drink contaminated with roundworm eggs causes infection. The eggs hatch and release larvae within the intestine. The larvae then move through the bloodstream to the lungs, exit up through the large airways of the lungs, and are swallowed back into the stomach and intestines.
| Product | Ascaris lumbricoides IgA ELISA |
| Cat. No. | EIA-3817 |
| Incubation | 60/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
Cryptosporidium
Cryptosporidium is a coccidian parasite recognised as an important enteric pathogen. The organism causes an acute, though self-limiting, infection in immunocompetent individuals. Incubation periods of 1 to 12 days have been reported, with most oocyst shedding ending by day 21. Symptoms range from mild to severe diarrhoea, with a variety of complications. In immunocompromised patients, the infection is much more severe and may often be life-threatening. Passage of fluid, up to 12 litres per day, has been reported. Multiple pathways of Cryptosporidium transmission have been implicated. These include animal-to-human, water contamination, and person-to-person transmission. The latter may include contact between members of the same household, in day-care centres, and among men.
| Product | Cryptosporidiu Antigen (Stool) ELISA |
| Cat. No. | EIA-3467 |
| Incubation | 60/30/10 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | 0,1 g |
| Sample Dilution | 1:4 |
| Specials |
Echinococcus
Echinococci are microscopic cestodes (tapeworms) with a length of 1.4 to 6 mm, depending on the genus.
E. granulosus is found in dogs or other canids, while E. multilocularis is found in foxes, coyotes, and wolves. Sources of infection are final hosts (i.e., dogs for E. granulosus and mainly foxes for E. multilocularis) and food contaminated with parasite eggs. After ingestion of a suitable intermediate host, the egg hatches in the small intestine and releases an oncosphere that penetrates the intestinal wall and travels through the circulatory system, into various organs where it develops into a cyst.
| Product | Echinococcus IgG ELISA |
| Cat. No. | EIA-3472 |
| Incubation | 60/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
Entamoeba Histolytica
E. histolytica is the protozoan parasite responsible for the disease amebiasis. Symptoms of acute amebiasis include diarrhoea and colitis. The disease may manifest itself as an acute, chronic, or asymptomatic infection. Additionally, a percentage of the intestinal amebic infections will become extra-intestinal and cause abscesses in various organs. If extra-intestinal amebiasis is suspected, a serology test should be used for diagnosis. By the time abscesses are occurring, the patient’s stools are usually clear of amoebas. The mode of transmission of E. histolytica is typically through the faecal-oral ingestion of cysts, often by drinking contaminated water. Epidemics of amebiasis have been documented in developed nations, but the parasite is quite common in underdeveloped countries. Travellers returning from underdeveloped countries account for the majority of cases in developed countries.
| Product | Entamoeba Histolytica IgG ELISA |
| Cat. No. | EIA-3830 |
| Incubation | 60/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
| Product | Entamoeba histolytica kits Ag (stool) ELISA |
| Cat. No. | EIA-3473 |
| Incubation | 60/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Stool 1 g |
| Sample Dilution | 1:4 |
| Specials | MOQ 5 kits |
Fasciola
Fascioliasis is a parasitic disease caused by liver fluke species of the genus Fasciola: Fasciola hepatica and Fasciola gigantica. While F. hepatica is found globally, F. gigantica can be found in humans and animals in tropical regions of Africa and Asia. However, in some parts of Africa and Asia, the two species overlap. Today, fascioliasis is considered an important human disease, and several geographic areas have been described as endemic for the disease in humans, including hypoendemic (prevalence < 1%), mesoendemic (prevalence between 1% and 10%), and hyperendemic (> 10%) situations, with intensities ranging from low to very high. Estimates suggest up to 17 million people are infected worldwide. This number may even be an underestimate, considering the lack of data from numerous Asian and African countries. Moreover, in the last two decades, human fascioliasis has been emerging in many regions, a phenomenon partly linked to climate change. Recent studies have shown that the high pathogenicity of this disease is not only restricted to the acute phase but also extends to long-term liver fluke infections, the immune modulation during the acute phase, and their immune suppression effect in chronic and advanced chronic stages. These factors are often observed alongside co-infections with other parasitic and infectious diseases.
| Product | Fasciola IgG ELISA |
| Cat. No. | EIA-4503 |
| Incubation | 60/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
Filariasis
Filariasis (or philariasis) is a parasitic disease caused by an infection with roundworms of the Filarioidea type. These are spread by blood-feeding blackflies and mosquitoes. This disease belongs to the group of diseases known as helminthiases. Eight known filarial nematodes use humans as their definitive hosts. These are divided into three groups according to the niche within the body they occupy:
- Wuchereria bancrofti, Brugia malayi, and Brugia timori cause Lymphatic filariasis.
- Loa loa (the eye worm), Mansonella streptocerca, and Onchocerca volvulus cause Subcutaneous filariasis (Loiasis; Streptocerciasis; Onchocerciasis).
- Mansonella perstans and Mansonella ozzardi cause Serous cavity filariasis (Perstans filariasis).
| Product | Filariasis ELISA |
| Cat. No. | EIA-5972 |
| Incubation | 60/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
Giardia Lamblia
Giardia lamblia is one of the most common human intestinal protozoan pathogens worldwide. The incidence strongly depends on the geographic region, reaching 2-7% in central Europe and exceeding 50% in tropical countries. The life cycle of Giardia lamblia is characterised by two stages: the trophozoite and the cyst stage. The trophozoite is the motile dividing stage and inhabits the upper small intestine. Ascending infections of the gallbladder may also occur. The cyst is the infective form of the parasite. It develops in the intestine and is excreted with the faeces. Cysts are transmitted via contaminated food or drinking water, but also from person to person.
| Product | Giardia lamblia Ag (stool) ELISA |
| Cat. No. | EIA-3477 |
| Incubation | 60/30/10 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Stool 50 μl / 100 μl/0.1 g |
| Sample Dilution | 1:2 / 1:8 |
| Specials | MOQ: 5 kits |
| Product | Giardia Lamblia Ag (stool) ELISA |
| Cat. No. | EIA-6059 |
| Incubation | 60/30/10 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Stool 50 μl / 100 μl/0.1 g |
| Sample Dilution | 1:2 / 1:8 |
| Specials | MOQ: 5 kits |
Leptospira
The clinical manifestations of leptospirosis can range from a mild catarrh-like illness to icteric disease with severe liver and kidney involvement. Natural reservoirs for leptospirosis include rodents, as well as a wide variety of domesticated mammals. The organisms reside in the lumen of nephritic tubules in their natural host and are shed into the urine. Human infection typically results from direct exposure to infected animals (such as veterinarians, abattoir workers, or dairy workers) or by exposure to environments contaminated by animal carriers (e.g., agricultural workers). Bathing or swimming in water sources contaminated by livestock has been shown to pose an infection risk. The organisms enter the host through skin abrasions, mucosal surfaces, or the eye. The incubation period can range from 3 to 30 days, but it is usually between 10 and 12 days. Antibodies may become detectable by the 6th to 10th day of illness, generally reaching peak levels within 3 to 4 weeks. Antibody levels then gradually decline but may remain detectable for years.
| Product | Leptospira IgG ELISA |
| Cat. No. | EIA-5751 |
| Incubation | 60/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
| Product | Leptospira IgM ELISA |
| Cat. No. | EIA-5752 |
| Incubation | 60/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
Malaria
Malaria is one of the most common diseases in the world, with more than half of the global population living in malaria-endemic areas. Over 200 million cases are reported annually, resulting in up to 3 million deaths each year, the majority of which involve young children. In non-endemic areas, malaria is one of the most important imported diseases, leading to several deaths each year in cases that are either diagnosed late or unsuspected. The disease is caused by protozoa of the genus Plasmodium, which are transmitted through the bite of the female Anopheles mosquito. Four species of Plasmodium cause human malaria: P. falciparum, P. vivax, P. malariae, and P. ovale. The disease may also be transmitted via transfusion of infected blood. Once in the bloodstream, the sporozoite makes its way to the liver, where it produces merozoites over the next two weeks.
| Product | Malaria Ab ELISA |
| Cat. No. | EIA-5511 |
| Incubation | 60/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
| Product | Malaria Ab ELISA |
| Cat. No. | EIA-5048 |
| Incubation | 60/60/30 |
| Testprinciple | Qualitative |
| Standard Range | 0-5 IU/ml |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:4 |
| Specials |
Schistosoma Mansoni (Bilharziosis)
Schistosomes belong to the class of distomas (trematodes) and are among the most frequent pathogens. It is estimated that more than 200 million people are affected by these parasites. The mature parasites range from 6 to 22 mm in length. The most important species are Schistosoma mansoni, S. japonicum, and S. haematobium. Schistosoma mansoni is common in Africa, South America, and the Middle East.
Schistosomiasis (also known as bilharzia) is, depending on the species and location of the parasites, a disease affecting the intestine, liver, spleen, or urinary passages. Humans are (re)infected through contact with fresh water contaminated with ova from infected urine or faeces. When larvae penetrate the human skin, an initial transient skin reaction occurs (itching, with exanthema or erythema). Repeated infections may lead to cercarial dermatitis.
| Product | Schistosoma mansoni IgG ELISA |
| Cat. No. | EIA-3872 |
| Incubation | 60/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
| Product | Schistosoma mansoni IgM ELISA |
| Cat. No. | EIA-5904 |
| Incubation | 60/10/3/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
Strongyloides
Strongyloides is a genus comprising around 50 species of obligate gastrointestinal parasites of vertebrates. Strongyloides stercoralis is the scientific name of the human parasitic roundworm responsible for causing strongyloidiasis. The S. stercoralis nematode can parasitise humans. The adult parasitic stage resides in tunnels within the mucosa of the small intestine. S. stercoralis is typically found in tropical and subtropical climates, although cases also occur in temperate regions, particularly in rural areas. The prevalence of S. stercoralis is very low in societies where faecal contamination of soil or water is rare. Many infected individuals remain asymptomatic initially.
Symptoms of the infection include dermatitis, characterised by swelling, itching, larva currens, and mild haemorrhage at the site where the skin has been penetrated. If the parasite migrates to the lungs, the chest may feel as though it is burning, and wheezing and coughing may occur, often accompanied by pneumonia-like symptoms (Löffler’s syndrome). The intestines may eventually be affected, resulting in burning pain, tissue damage, sepsis, and ulcers. In severe cases, oedema may cause obstruction of the intestinal tract and loss of peristaltic contractions.
| Product | Strongyloides IgG ELISA |
| Cat. No. | EIA-4208 |
| Incubation | 10/5/5 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 5 μl |
| Sample Dilution | 1:64 |
| Specials |
| Product | Strongyloides IgG/IgM ELISA |
| Cat. No. | EIA-5812 |
| Incubation | 60/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 5 μl |
| Sample Dilution | 1:101 |
| Specials |
Toxocara Canis
Toxocara canis (an ascarid) is a parasitic nematode (roundworm) commonly found in the intestine of dogs. Humans are paratenic hosts and become infected by ingesting infective eggs from contaminated soil. After ingestion, the eggs hatch into larvae that penetrate the intestinal wall and are carried through the circulation to various tissues (liver, heart, lungs, brain, muscle, eyes). While the larvae do not undergo further development in these sites, they can cause local reactions that form the basis of toxocariasis. In most cases, Toxocara infections are not severe, and many people—particularly adults infected by a small number of larvae (immature worms)—may not experience symptoms. The most severe cases are rare but are more likely to occur in young children, who often play in dirt or eat soil contaminated by dog faeces. The two main clinical presentations of toxocariasis are Ocular Larva Migrans (OLM), an eye disease that can lead to blindness (each year, over 700 people infected with Toxocara experience permanent partial loss of vision), and Visceral Larva Migrans (VLM), a disease that causes swelling of the body’s organs or the central nervous system.
| Product | Toxocara canis IgG ELISA |
| Cat. No. | EIA-3865 |
| Incubation | 60/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
Toxoplasma Gondii
Toxoplasma gondii is a small intracellular parasite, with a life cycle consisting of both a sexual and an asexual phase. Sexual development occurs exclusively in the intestinal cells of cats (likely the only hosts), where oocysts are formed and excreted. Due to their resistant cell walls, the oocysts may remain infectious for up to a year under favourable conditions. Animals and humans serve as intermediate hosts for the asexual proliferation of T. gondii; once ingested, the parasites proliferate explosively within host cells, eventually lysing them. The parasites spread throughout the body via the bloodstream and lymphatic system, potentially infecting any type of cell.
| Product | Toxoplasma gondii IgA ELISA |
| Cat. No. | EIA-3683 |
| Incubation | 60/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
| Product | Toxoplasma gondii IgG ELISA |
| Cat. No. | EIA-3519 |
| Incubation | 60/30/15 |
| Testprinciple | Quantitative |
| Standard Range | 50-200 IU/ml |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
| Product | Toxoplasma gondii IgG Avidity ELISA |
| Cat. No. | EIA-5965 |
| Incubation | 60/10/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
| Product | Toxoplasma gondii IgM ELISA |
| Cat. No. | EIA-3520 |
| Incubation | 60/30/15 |
| Testprinciple | Quantitative |
| Standard Range | 25-100 DU/ml |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
Trichinella Spiralis
Trichinosis (also known as trichinellosis) is caused by nematodes (roundworms) of the genus Trichinella. In addition to the classical agent Trichinella spiralis, which is found worldwide in many carnivorous and omnivorous animals, four other species (T. pseudospiralis, T. nativa, T. nelsoni, and T. britovi) are recognised. Trichinosis is acquired by ingesting meat containing cysts of Trichinella. After exposure to gastric acid and pepsin, the larvae are released from the cysts and invade the small bowel mucosa, where they develop into adult worms (females measuring 2.2 mm in length, males 1.2 mm). After one week, the females release larvae that migrate to the striated muscles, where they encyst. Encystment is completed in 4 to 5 weeks, and the encysted larvae may remain viable for several years. Ingestion of the encysted larvae perpetuates the cycle.
Trichinosis occurs worldwide but is most common in parts of Europe and the United States. Light infections may be asymptomatic. For mild to moderate infections, most symptoms subside within a few months, while fatigue, weakness, and diarrhoea may last for several months. In severe cases, death can occur.
| Product | Trichinella spiralis IgG ELISA |
| Cat. No. | EIA-3866 |
| Incubation | 60/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
Trypanosoma Cruzi (Chagas)
Chagas’ disease occurs in Central and South America. It is an infectious disease transmitted to humans through the bite wound caused by an infected bug of the family Reduviidae. The infection is caused by Trypanosoma cruzi, a unicellular parasite. The infection progresses through different phases and often results in a chronic disease. An estimated 4 to 5 million people in South America are suffering from it. People living in poor conditions are particularly at risk. Up to 10% of all infections are fatal, with babies and neonates being especially vulnerable.
The infection is transmitted to humans by different bug species of the family Reduviidae. The parasite does not enter the human body via the bite of the bug. Trypanosoma cruzi lives in the faeces of the bug and invades humans through skin wounds. Newborns are at risk through in utero infection. Transmission via blood transfusion is also possible.
1-2% of all infected individuals show symptoms after an incubation period of one to four weeks. Children up to 15 years old are primarily affected. The disease progresses through three different phases. During the acute phase, fever, diarrhoea, abdominal pain, swollen lymph nodes, and general swelling appear. In neonates and infants, inflammation of the heart or brain may occur. The acute phase lasts for approximately 4 weeks. Acute Chagas disease primarily affects children and in many cases, the disease resolves on its own.
The subsequent latency period is characterised by a lack of symptoms for most patients. Occasionally, there is a weakening of the immune system. This phase can last for several years. 10 to 20% of infected people progress to the chronic phase. Various internal organs, such as the heart, intestinal tract, or nervous system, can be affected. Patients often die due to sudden cardiac death or as a result of chronic heart failure. The prognosis depends on the degree of heart involvement. Various diagnostic methods are used, but detection of antibodies to T. cruzi antigens remains the most reliable method for diagnosing the infection.
| Product | Chagas (Trypanosoma cruzi) IgG ELISA |
| Cat. No. | EIA-5813 |
| Incubation | 60/30/15 |
| Testprinciple | Qualitative |
| Standard Range | |
| Sample Volume | Serum/Plasma 10 μl |
| Sample Dilution | 1:101 |
| Specials |
How Aspect Scientific can improve your ELISA testing
Improved accuracy
Consistent results with fewer errors and greater confidence
Faster Turnaround
Process more samples quickly and deliver results sooner
Greater Capacity
Handle growing workloads with ease and efficiency
Reduced Costs
Save time and resources while lowering long term costs
Diagnostic testing has never been easier